CANCHID Archives

Canadian Network on Health in Development

CANCHID@YORKU.CA

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-type:
text/plain; charset=ISO-8859-1
Sender:
Canadian Network on Health in Development <[log in to unmask]>
Subject:
From:
Cathi Raymond-Martin <[log in to unmask]>
Date:
Fri, 24 Mar 2000 17:26:59 EST
Content-Transfer-Encoding:
quoted-printable
MIME-Version:
1.0
Reply-To:
Parts/Attachments:
text/plain (127 lines)
Form: Reply
Text: (124 lines follow)
I will be away from the office from March 22, 2000 returning March 27th.
Your message will be saved.  If you require urgent assistance, please contact
Rosemary Kennedy by e-mail [log in to unmask] or by telephone (613) 236-6163,
Ext. 2154 Thank you.

Cathi Raymond-Martin
Program Assistant
Research for International Tobacco Control
Tel:  (613) 236-6163 Ext. 2446
Fax:  (613) 236-4026
e-mail:  [log in to unmask]
---------- Original Text ----------

From: "Chuck Shields" <[log in to unmask]>, on 2000/03/24 4:30 PM:
To: iSMTP@HQNT11@Servers[<[log in to unmask]>]

This is shaping up to be an exciting conference, with over 200 abstracts and
registrants from more than 40 countries:

Landmark International Women's Health Conference

Who:    The Heart and Stroke Foundation of Canada, the American Heart
Association, Health Canada, the Centers for Disease Control and Prevention
(U.S.A.) and the Canadian Cardiovascular Society
                                Present the
                                First International Conference on Women,
Heart Disease and Stroke: Science and Policy in Action

Where:          Victoria Conference Centre
                Victoria, British Columbia, Canada

When:           Sunday May 7 to Wednesday May 10, 2000

What:   For the first time in history, health professionals from around the
world will come together to discuss the latest in science, policy and
practice as they relate to the prevention, treatment and rehabilitation of
heart disease and stroke in women - a growing epidemic that will soon be the
number one cause of death worldwide.  One hundred abstracts and 120 posters
will be presented.

Topics of interest:

*       Hormone Replacement Therapy
*       Gender and Equity
*       Young Women and Tobacco
*       Global Issues in Monitoring Cardiovascular Disease and Related
Behaviours
*       Integrated Approaches to Cardiovascular Disease Prevention: A Focus
on Women's Health
*       Women and Stress:  The Effects of Being Everything to Everybody
Everytime
*       Risk Factor Management and Control for Women
*       Diagnosis and Treatment of Heart Disease and Stroke in Women
*       PLUS keynote addresses by prominent professionals from around the
world

        Supporters:     Wyeth-Ayerst Laboratories
                        Eli Lilly and Company
                        Bristol-Myers Squibb Company
                        Aventis Pharmaceuticals
                        Procter and Gamble Pharmaceuticals Inc
                        Pfizer Inc
                        Canadian International Development Agency
                        Health Canada
                        Imperial Order of the Daughters of the Empire -
Amelia F. Sims Chapter

        Visit the Conference Web site at www.hsf.ca/women&cvd2000




        Importante conférence internationale sur la santé des femmes

        Qui :   La Fondation des maladies du coeur du Canada, l'American
Heart Association, Santé Canada, le Centers for Disease Control and
Prevention (É.-U.) et la Société canadienne de cardiologie
                                présentent la
                                Les femmes, les maladies du coeur et les
accidents vasculaires cérébraux : première conférence internationale

        Où :          Centre des congrès de Victoria
                        Victoria (Colombie-Britannique) Canada

        Quand : Du dimanche 7 mai au mercredi 10 mai 2000

        Quoi :  Pour une première fois historique, les professionnels de la
santé des quatre coins du monde viendront discuter ensemble des derniers
développements scientifiques, politiques et pratiques reliés à la
prévention, au traitement et à la réadaptation des maladies
cardiovasculaires et des accidents vasculaires cérébraux (AVC) chez les
femmes - une épidémie en pleine croissance en passe de devenir la première
cause de décès dans le monde. 100 résumés de recherche et 120 affiches y
seront présentés.

        Sujets d'intérêt :

*       L'hormonothérapie de remplacement
*       Genre et équité
*       Le tabac chez les jeunes femmes
*       Les questions globales de surveillance des maladies
cardiovasculaires et des comportements qui y sont associés
*       Les approches intégrées en prévention des maladies cardiovasculaires
: pleins feux sur la santé des femmes
*       Les femmes et le stress : les conséquences d'être toujours tout pour
tout le monde
*       La gestion et le contrôle des facteurs de risque chez les femmes
*       Diagnostic et traitement des maladies cardiovasculaires et des AVC
chez les femmes
*       EN PLUS, des discours d'éminents professionnels de partout dans le
monde

Partenaires:    Wyeth-Ayerst Laboratories
                Eli Lilly and Company
                Bristol-Myers Squibb Company
                Aventis Pharmaceuticals
                Procter and Gamble Pharmaceuticals Inc
                Pfizer Inc
                Santé Canada
                Agence canadienne de dévéloppement international
                Imperial Order of the Daughters of the Empire - Amelia F.
Sims Chapter

Visitez le site Internet de la conférence au www.hsf.ca/mcv2000etlafemme

ATOM RSS1 RSS2